• Mondis Technology Ltd. v. LG Electronics, Inc. (D.N.J.). Represented Mondis in case against LG’s digital televisions that implement HDMI and VESA plug-and-play technology.  Obtained US$45M jury verdict.
    • Endo Pharmaceuticals v. Teva, et al. (S.D.N.Y.). Trial counsel for Endo Pharmaceuticals in Hatch-Waxman Act case filed against a dozen ANDA filers involving Endo's OPANA® ER product. Following a five-week trial, the court ruled in Endo's favor, finding its patents valid and infringed. Dechert later secured Federal Circuit affirmance of its hard-fought patent trial victory while the case was on appeal, enjoining all generics through 2023.
    • Member of litigation team representing multinational manufacturers of generic pharmaceuticals in Hatch-Waxman patent litigation and appeals.
    • Member of litigation team representing seller of a midtown Manhattan office building prosecuting claims for breach of Purchase and Sale Agreement by ostensible purchaser, winning a motion for summary judgment allowing seller to retain a US $38.5 million deposit on the sale, plus interest.
    • Member of trial team representing a large financial institution in an eight-day bench trial in the Southern District of New York. After a defense verdict for the financial institution at trial the case settled favorably on appeal. 

    Includes matters handled at Dechert or prior to joining the firm.

  • Federal Circuit Court of Appeals Tailors Its Decision on Skinny Labels - Intellectual Property & Technology Law Journal (November 2, 2021)